Managing drug-induced psychosis

References

• Arunogiri, S., Foulds, J. A., McKetin, R., & Lubman, D. I. (2018). A systematic review of risk factors for methamphetamine-associated psychosis. The Australian and New Zealand Journal of Psychiatry, 52(6), 514–529. doi: 10.1177/0004867417748750.
   PubMed Web of Science ®Google Scholar
• Baldaçara, L., Diaz, A. P., Leite, V., Pereira, L. A., Dos Santos, R. M., Gomes Junior, V. P., Calfat, E. L. B., Ismael, F., Perico, C. A. M., Porto, D. M., Zacharias, C. E. K., Cordeiro, Q., da Silva, A. G., & Tung, T. C. (2019a). Brazilian guidelines for the management of psychomotor agitation. Part 2. Pharmacological approach. Revista Brasileira de Psiquiatria , 41(4), 324–335. doi: 10.1590/1516-4446-2018-0177.
   PubMedGoogle Scholar
• Baldaçara, L., Grudtner, R. R., da S Leite, V., Porto, D. M., Robis, K. P., Fidalgo, T. M., Rocha, G. A., Diaz, A. P., Meleiro, A., Correa, H., Tung, T. C., Malloy-Diniz, L., Quevedo, J., & da Silva, A. G. (2021). Brazilian Psychiatric Association guidelines for the management of suicidal behavior. Part 2. Screening, intervention, and prevention. Revista Brasileira de Psiquiatria, 43(5), 538–549. doi: 10.1590/1516-4446-2020-1108.
   PubMedGoogle Scholar
• Baldaçara, L., Ismael, F., Leite, V., Pereira, L. A., Dos Santos, R. M., Gomes Junior, V. P., Calfat, E., L., B., Diaz, A. P., Perico, C. A. M., Porto, D. M., Zacharias, C. E., Cordeiro, Q., da Silva, A. G., & Tung, T. C. (2019b). Brazilian guidelines for the management of psychomotor agitation. Part 1. Non-pharmacological approach. Revista Brasileira de Psiquiatria, 41(2), 153–167. doi: 10.1590/1516-4446-2018-0163.
   PubMedGoogle Scholar
• Baldaçara, L., Pettersen, A. G., Leite, V. D. S., Ismael, F., Motta, C. P., Freitas, R. A., Fasanella, N. A., Pereira, L. A., Barros, M. E. L., Barbosa, L., Teles, A. L. S., Palhano, R., Guimaraes, H. P., Braga, M. A., Castaldelli-Maia, J. M., Bicca, C., Gligliotti, A., Marques, A., & da Silva, A. G. (2022a). Brazilian Psychiatric Association consensus for the management of acute intoxication. General management and specific interventions for drugs of abuse. Trends in Psychiatry and Psychotherapy, doi: 10.47626/2237-6089-2022-0571.
   PubMedGoogle Scholar
• Baldaçara, L., Rocha, G. A., Leite, V. D. S., Porto, D. M., Grudtner, R. R., Diaz, A. P., Meleiro, A., Correa, H., Tung, T. C., Quevedo, J., & da Silva, A. G. (2021). Brazilian Psychiatric Association guidelines for the management of suicidal behavior. Part 1. Risk factors, protective factors, and assessment. Revista Brasileira de Psiquiatria, 43(5), 525–537. doi: 10.1590/1516-4446-2020-0994.
   PubMedGoogle Scholar
• Baldaçara, L., Weber, C. A. T., Gorender, M., Grudtner, R. R., Peu, S., Teles, A. L. S., Cavalcante, I. P., Quevedo, J., & da Silva, A. G. (2022b). Brazilian Psychiatric Association guidelines for the management of suicidal behavior. Part 3. Suicide prevention hotlines. Brazilian Journal of Psychiatry, 1345(1), 54–61.
   Google Scholar
• Brown, H. E., Kaneko, Y., & Donovan, A. L. (2019). Substance-induced psychosis and co-occurring psychotic disorders. Substance Use and the Acute Psychiatric Patient,
   Google Scholar
• Crebbin, K., Mitford, E., Paxton, R., & Turkington, D. (2009). First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group. Social Psychiatry and Psychiatric Epidemiology, 44(9), 710–715. doi: 10.1007/s00127-008-0490-2.
   PubMed Web of Science ®Google Scholar
• Excellence. (2011). NICE clinical guideline 120. Psychosis with coexisting substance misuse: assessment and management in adults and young people. p. 39.
   Google Scholar
• Farnia, V., Shakeri, J., Tatari, F., Juibari, T. A., Yazdchi, K., Bajoghli, H., Brand, S., Abdoli, N., & Aghaei, A. (2014). Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis. The American Journal of Drug and Alcohol Abuse, 40(1), 10–15. doi: 10.3109/00952990.2013.861843.
   PubMed Web of Science ®Google Scholar
• Fiorentini, A., Cantu, F., Crisanti, C., Cereda, G., Oldani, L., & Brambilla, P. (2021). Substance-induced psychoses: An updated literature review. Frontiers in Psychiatry, 12, 694863. doi: 10.3389/fpsyt.2021.694863.
   PubMed Web of Science ®Google Scholar
• Garriga, M., Pacchiarotti, I., Kasper, S., Zeller, S. L., Allen, M. H., Vazquez, G., Baldaçara, L., San, L., McAllister-Williams, R. H., Fountoulakis, K. N., Courtet, P., Naber, D., Chan, E. W., Fagiolini, A., Moller, H. J., Grunze, H., Llorca, P. M., Jaffe, R. L., Yatham, L. N., … Vieta, E. (2016). Assessment and management of agitation in psychiatry: Expert consensus. The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry, 17(2), 86–128. doi: 10.3109/15622975.2015.1132007.
   PubMed Web of Science ®Google Scholar
• Ghose, S. (2018). Substance-induced psychosis: An indicator of development of primary psychosis? The American Journal of Psychiatry, 175(4), 303–304. doi: 10.1176/appi.ajp.2018.17121395.
   PubMed Web of Science ®Google Scholar
• Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., Ware, M., Marmorstein, N., Cipriani, A., Dendukuri, N., & Mayo, N. (2019). Association of Cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis. Joutnal of American Medical Association Psychiatry, 76(4), 426–434. doi: 10.1001/jamapsychiatry.2018.4500.
   Google Scholar
• Griswold, K. S., Del Regno, P. A., & Berger, R. C. (2015). Recognition and differential diagnosis of psychosis in primary care. American Family Physician, 91(12), 856–863.
   PubMed Web of Science ®Google Scholar
• Hirjak, D., Meyer-Lindenberg, A., Brandt, G. A., & Dreßing, H. (2022). Differential diagnostic distinction between substance-induced and primary psychoses: Recommendations for general psychiatric and forensic practice]. Der Nervenarzt, 93(1), 11–23. [doi: 10.1007/s00115-021-01083-3.
   PubMed Web of Science ®Google Scholar
• Lechner, W. V., Dahne, J., Chen, K. W., Pickover, A., Richards, J. M., Daughters, S. B., & Lejuez, C. W. (2013). The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms. Drug and Alcohol Dependence, 131(1–2), 78–84. doi: 10.1016/j.drugalcdep.2012.12.003.
   PubMed Web of Science ®Google Scholar
• Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016). Meta-analysis of the association between the level of Cannabis use and risk of psychosis. Schizophrenia Bulletin, 42(5), 1262–1269. doi: 10.1093/schbul/sbw003.
   PubMed Web of Science ®Google Scholar
• Mauri, M. C., Di Pace, C., Reggiori, A., Paletta, S., & Colasanti, A. (2017). Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up. Asian Journal of Psychiatry, 29, 117–122. doi: 10.1016/j.ajp.2017.04.014.
   PubMed Web of Science ®Google Scholar
• Nathan, R., & Lewis, E. (2021). Assessment of coexisting psychosis and substance misuse: complexities, challenges and causality. BJPsych Advances, 27(1), 38–48. doi: 10.1192/bja.2020.45.
   Google Scholar
• Nuevo, R., Chatterji, S., Verdes, E., Naidoo, N., Arango, C., & Ayuso-Mateos, J. L. (2012). The continuum of psychotic symptoms in the general population: a cross-national study. Schizophrenia Bulletin, 38(3), 475–485. doi: 10.1093/schbul/sbq099.
   PubMed Web of Science ®Google Scholar
• Pearson, N. T., & Berry, J. H. (2019). Cannabis and psychosis through the lens of DSM-5. International Journal of Environmental Research and Public Health, 16(21), 4149. doi: 10.3390/ijerph16214149.
   PubMed Web of Science ®Google Scholar
• Rentero, D., Arias, F., Sanchez-Romero, S., Rubio, G., & Rodriguez-Jimenez, R. (2021). Cannabis-induced psychosis: Clinical characteristics and its differentiation from schizophrenia with and without cannabis use. Adicciones, 33(2), 95–108. doi: 10.20882/adicciones.1251.
   PubMed Web of Science ®Google Scholar
• Roncero, C., Ros-Cucurull, E., Daigre, C., & Casas, M. (2012). Prevalence and risk factors of psychotic symptoms in cocaine-dependent patients. Actas Espanolas de Psiquiatria, 40(4), 187–197.
   PubMed Web of Science ®Google Scholar
• Shah, D., Chand, P., Bandawar, M., Benegal, V., & Murthy, P. (2017). Cannabis induced psychosis and subsequent psychiatric disorders. Asian Journal of Psychiatry, 30, 180–184. doi: 10.1016/j.ajp.2017.10.003.
   PubMed Web of Science ®Google Scholar
• Shoptaw, S. J., Kao, U., & Ling, W. (2009). Treatment for amphetamine psychosis. The Cochrane Database of Systematic Reviews, 2009(1), CD003026. doi: 10.1002/14651858.CD003026.pub3.
   PubMedGoogle Scholar
• Smith, M. J., Thirthalli, J., Abdallah, A. B., Murray, R. M., & Cottler, L. B. (2009). Prevalence of psychotic symptoms in substance users: A comparison across substances. Comprehensive Psychiatry, 50(3), 245–250. doi: 10.1016/j.comppsych.2008.07.009.
   PubMed Web of Science ®Google Scholar
• Starzer, M. S. K., Nordentoft, M., & Hjorthoj, C. (2018). Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis. The American Journal of Psychiatry, 175(4), 343–350. doi: 10.1176/appi.ajp.2017.17020223.
   PubMed Web of Science ®Google Scholar
• Valmaggia, L. R., Day, F. L., Jones, C., Bissoli, S., Pugh, C., Hall, D., Bhattacharyya, S., Howes, O., Stone, J., Fusar-Poli, P., Byrne, M., & McGuire, P. K. (2014). Cannabis use and transition to psychosis in people at ultra-high risk. Psychological Medicine, 44(12), 2503–2512. doi: 10.1017/S0033291714000117.
   PubMed Web of Science ®Google Scholar
• Verachai, V., Rukngan, W., Chawanakrasaesin, K., Nilaban, S., Suwanmajo, S., Thanateerabunjong, R., Kaewkungwal, J., & Kalayasiri, R. (2014). Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine. Psychopharmacology, 231(16), 3099–3108. doi: 10.1007/s00213-014-3485-6.
   PubMed Web of Science ®Google Scholar
• WHO. (2018). International Classification of Diseases, 11th Revision (ICD-11). WHO.
   Google Scholar
• Wilson, L., Szigeti, A., Kearney, A., & Clarke, M. (2018). Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review. Schizophrenia Research, 197, 78–86. doi: 10.1016/j.schres.2017.11.001.
   PubMed Web of Science ®Google Scholar